title: Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.
abstract: Serum exosomes containing noncoding RNA (ncRNA) play an important role in both physiological and pathological conditions. However, biological function of exosomal ncRNA remains unclear. The aim of the study was to investigate the prognostic and diagnostic values of exosomal ncRNA by comparing the amounts of exosomal miR-21 and HOTAIR in serum of laryngeal squamous cell carcinoma (LSCC) patients with those of polyps of vocal cords, and by determinating whether combined detection of the two molecules could provide useful information in the diagnosis of LSCC. Exosomes were isolated from the serum samples of 52 LSCC patients and those of 49 patients with polyps of vocal cords. TEM and Western blot were applied for the confirmation of isolated exosomes by observing the ultra structure and testing CD63 marker protein, respectively. RT-PCR was performed to detect the expression of miR-21 and HOTAIR in the exosomes. The receiver-operating characteristic (ROC) curve was generated to examine the prognostic value of the two molecules. The expression of exosomal miR-21 and HOTAIR was significantly higher in patients with LSCC than those with vocal cord polyps. There were significant differences of serum exosomal miR-21 and HOTAIR expressions between the advanced T classifications (T3/T4) or clinical stages (III/IV) and the early stages. The patients with lymph node metastasis had higher serum exosomal miR-21 and HOTAIR expressions than those without. There were no differences between patient sex, tumor locations and differentiations. The area under the ROC curve of combined examination of exosomal HOTAIR and miR-21 for diagnosing LSCC was 87.6 %, which was significantly higher than 80.1 % of miR-21 (p = 0.0359) or 72.7 % of HOTAIR (p = 0.0012), showing 94.2 and 73.5 % of sensitivity and specificity, respectively, in differentiating the malignant from benign laryngeal disease. Serum exosomal miR-21 and HOTAIR were significantly correlated with clinical parameters of LSCC, and combined evaluation of their serum expressions may be a valuable biomarker to screen LSCC and might be a promising predicting tool for LSCC patient.
authors.affiliation: Department of Otorhinolaryngology, Head and Neck Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, 150081, China.
authors.forename: Jingting
authors.initials: J
authors.lastname: Wang
authors.forename: Yandong
authors.initials: Y
authors.lastname: Zhou
authors.forename: Jianguang
authors.initials: J
authors.lastname: Lu
authors.forename: Yanan
authors.initials: Y
authors.lastname: Sun
authors.forename: Hui
authors.initials: H
authors.lastname: Xiao
authors.forename: Ming
authors.initials: M
authors.lastname: Liu
authors.forename: Linli
authors.initials: L
authors.lastname: Tian
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D015331:Cohort Studies; D055354:Exosomes / Q000737:chemistry*; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D008297:Male; D035683:MicroRNAs / Q000097:blood*; D008875:Middle Aged; D011127:Polyps / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology; D011379:Prognosis; D062085:RNA, Long Noncoding / Q000097:blood*; D012372:ROC Curve
chemical_list: D014408:Biomarkers, Tumor; C561566:HOTAIR long untranslated RNA, human; C524940:MIRN21 microRNA, human; D035683:MicroRNAs; D062085:RNA, Long Noncoding
references.citation: Clin Chem. 2010 Nov;56(11):1733-41
references.pmid: 20847327
references.citation: Crit Rev Oncol Hematol. 2011 Nov;80(2):193-208
references.pmid: 21145252
references.citation: Am J Pathol. 2013 Jan;182(1):64-70
references.pmid: 23141928
references.citation: Oncol Rep. 2014 May;31(5):2029-34
references.pmid: 24676647
references.citation: Eur J Cancer. 2010 Dec;46(18):3409-16
references.pmid: 20801640
references.citation: J Transl Med. 2014 Jan 06;12:4
references.pmid: 24393345
references.citation: Anticancer Res. 2014 Feb;34(2):665-9
references.pmid: 24510997
references.citation: Cancer Med. 2012 Oct;1(2):128-40
references.pmid: 23342263
references.citation: PLoS One. 2010 Oct 08;5(10):e13247
references.pmid: 20949044
references.citation: J Extracell Vesicles. 2013 Jun 18;2:
references.pmid: 24009888
references.citation: BMC Cancer. 2012 Sep 24;12:421
references.pmid: 22998595
references.citation: Mol Cell. 2010 Jul 9;39(1):133-44
references.pmid: 20603081
references.citation: Tumour Biol. 2014 Jun;35(6):5953-63
references.pmid: 24682952
references.citation: Cancer Sci. 2010 Oct;101(10):2087-92
references.pmid: 20624164
references.citation: PLoS One. 2012;7(3):e30679
references.pmid: 22427800
references.citation: Br J Cancer. 2013 Feb 19;108(3):644-52
references.pmid: 23361059
references.citation: Ann Oncol. 2005 Mar;16(3):481-8
references.pmid: 15718248
references.citation: Med Oncol. 2014 Jan;31(1):785
references.pmid: 24297308
references.citation: Clin Cancer Res. 2011 Mar 1;17(5):959-64
references.pmid: 21224375
references.citation: Otolaryngol Clin North Am. 2008 Aug;41(4):673-95, v
references.pmid: 18570953
references.citation: BMC Genomics. 2013 May 10;14:319
references.pmid: 23663360
references.citation: PLoS One. 2013 Oct 09;8(10):e78649
references.pmid: 24130905
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Laryngoscope. 2014 Apr;124(4):913-5
references.pmid: 24515562
references.citation: Proteomics. 2013 May;13(10-11):1572-80
references.pmid: 23129434
references.citation: Nat Rev Genet. 2011 Nov 18;12(12):861-74
references.pmid: 22094949
references.citation: Traffic. 2002 May;3(5):321-30
references.pmid: 11967126
references.citation: Br J Haematol. 2008 May;141(5):672-5
references.pmid: 18318758
references.citation: PLoS One. 2013 Oct 23;8(10):e77829
references.pmid: 24194897
references.citation: Methods Mol Biol. 2013;1024:157-72
references.pmid: 23719949
references.citation: Cancer. 2013 Mar 15;119(6):1159-67
references.pmid: 23224754
references.citation: Biomed Rep. 2013 Jul;1(4):495-498
references.pmid: 24648974
references.citation: Nature. 2013 Mar 21;495(7441):333-8
references.pmid: 23446348
references.citation: Clin Biochem. 2014 Jan;47(1-2):135-8
references.pmid: 24183884
references.citation: Nat Rev Immunol. 2009 Aug;9(8):581-93
references.pmid: 19498381
references.citation: Differentiation. 2002 Dec;70(9-10):537-46
references.pmid: 12492495
references.citation: Anticancer Res. 2013 Mar;33(3):1141-6
references.pmid: 23482793
references.citation: Leukemia. 2006 Sep;20(9):1487-95
references.pmid: 16791265
references.citation: Clin Cancer Res. 2008 May 1;14(9):2588-92
references.pmid: 18451220
references.citation: Br J Radiol. 2014 Apr;87(1036):20130677
references.pmid: 24649835